Jean-Pierre Timmermans Selected Research

Jean-Pierre Timmermans Research Topics

Disease

20	Inflammation (Inflammations) 12/2021 - 06/2003
8	Atherosclerotic Plaque (Atheroma) 01/2016 - 06/2006
7	Colitis 03/2024 - 01/2008
5	Pain (Aches) 01/2022 - 05/2013
5	Atherosclerosis 01/2018 - 05/2008
5	Necrosis 01/2016 - 06/2006
4	Neoplasms (Cancer) 03/2024 - 09/2012
4	Hypersensitivity (Allergy) 01/2019 - 03/2009
4	Myocardial Infarction 01/2018 - 05/2005
4	Infarction (Infarctions) 01/2013 - 05/2005
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2014 - 01/2008
3	Schistosomiasis mansoni 05/2013 - 05/2002
3	Hypoxia (Hypoxemia) 01/2013 - 08/2002
2	Infections 01/2021 - 05/2008
2	Weight Loss (Weight Reduction) 01/2020 - 01/2008
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 08/2002
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2013 - 05/2012
2	Ileitis 05/2013 - 08/2012
2	Ischemia 12/2012 - 04/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2012 - 05/2008
2	Portal Hypertension 01/2011 - 01/2010
2	Ileus 08/2009 - 09/2008
2	Osteopetrosis 03/2008 - 04/2007
2	Ganglion Cysts (Ganglion) 09/2003 - 10/2002
1	Non-alcoholic Fatty Liver Disease 02/2022
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2022
1	Adenocarcinoma 01/2022
1	Lewis Lung Carcinoma 01/2022
1	Stroke (Strokes) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Visceral Leishmaniasis (Kala Azar) 01/2021
1	Neuroinflammatory Diseases 11/2020
1	Sepsis (Septicemia) 01/2020

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 07/2020 - 06/2006
7	CytokinesIBA 07/2020 - 01/2011
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2008 - 08/2002
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 05/2013
4	Messenger RNA (mRNA)IBA 01/2018 - 01/2007
4	Adenosine Triphosphate (ATP)IBA 01/2015 - 04/2008
4	Everolimus FDA Link 06/2013 - 02/2007
3	AcidsIBA 08/2020 - 01/2015
3	Peptides (Polypeptides)IBA 01/2011 - 08/2009
3	Nitric Oxide Synthase (NO Synthase)IBA 04/2008 - 08/2002
3	Superoxides (Superoxide)IBA 04/2008 - 05/2005
2	Dextran SulfateIBA 03/2024 - 01/2008
2	Dextrans (Dextran)FDA Link 03/2024 - 07/2020
2	Substance PIBA 01/2022 - 10/2002
2	InflammasomesIBA 11/2020 - 01/2013
2	sym-trinitrobenzeneIBA 08/2020 - 05/2013
2	LipopolysaccharidesIBA 01/2020 - 10/2018
2	Alkaline PhosphataseIBA 01/2020 - 03/2008
2	alpha-Crystallins (alpha-Crystallin)IBA 01/2019 - 08/2010
2	Apolipoproteins E (ApoE)IBA 01/2018 - 01/2016
2	Tryptases (Tryptase)IBA 01/2018 - 05/2002
2	Oxygen (Dioxygen)IBA 01/2018 - 05/2003
2	Carrier Proteins (Binding Protein)IBA 01/2018 - 05/2010
2	PolymersIBA 08/2014 - 06/2013
2	Peroxidase (Myeloperoxidase)IBA 01/2014 - 01/2008
2	Small Heat-Shock ProteinsIBA 07/2013 - 08/2010
2	AntibodiesIBA 05/2013 - 05/2002
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2013 - 11/2011
2	Imiquimod (Aldara)FDA LinkGeneric 01/2013 - 05/2012
2	LigandsIBA 01/2013 - 05/2012
2	PurinesIBA 10/2012 - 06/2004
2	TOR Serine-Threonine KinasesIBA 05/2012 - 02/2007
2	Myosin Type IIIBA 01/2011 - 01/2010
2	Cycloheximide (Cicloheximide)IBA 06/2009 - 03/2007
2	Protein Synthesis InhibitorsIBA 06/2009 - 03/2007
2	Soluble Guanylyl CyclaseIBA 09/2008 - 01/2008
2	Folic Acid (Vitamin M)FDA LinkGeneric 05/2008 - 04/2008
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 09/2003 - 05/2003
1	SodiumIBA 03/2024
1	Vasoconstrictor AgentsIBA 02/2022
1	Moxifloxacin (Avelox)FDA Link 01/2022
1	anti-IgE antibodiesIBA 01/2022
1	AllergensIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Rhodopsin (Visual Purple)IBA 01/2022
1	SecretagoguesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 12/2021
1	Phosphotransferases (Kinase)IBA 12/2021
1	Firefly LuciferasesIBA 01/2021
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 01/2021
1	Red Fluorescent ProteinIBA 01/2021
1	miltefosine (Impavido)IBA 01/2021
1	fluorescent protein 583IBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 08/2020
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 07/2020
1	MucinsIBA 07/2020
1	fluorescein isothiocyanate dextranIBA 07/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020

Therapy/Procedure

9	Therapeutics 01/2022 - 06/2006
5	Stents 09/2013 - 02/2007
3	Drug Therapy (Chemotherapy) 01/2022 - 09/2012
2	Drug-Eluting Stents 08/2014 - 06/2013
1	Heterologous Transplantation (Xenotransplantation) 03/2024
1	Immunotherapy 01/2022
1	Ligation 01/2020
1	Punctures 01/2020